These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 14975742

  • 1. Effect on ribonucleotide reductase of novel lipophilic iron chelators: the desferri-exochelins.
    Hodges YK, Antholine WE, Horwitz LD.
    Biochem Biophys Res Commun; 2004 Mar 12; 315(3):595-8. PubMed ID: 14975742
    [Abstract] [Full Text] [Related]

  • 2. Desferri-exochelin induces death by apoptosis in human breast cancer cells but does not kill normal breast cells.
    Pahl PM, Horwitz MA, Horwitz KB, Horwitz LD.
    Breast Cancer Res Treat; 2001 Sep 12; 69(1):69-79. PubMed ID: 11759830
    [Abstract] [Full Text] [Related]

  • 3. A lipid-soluble iron chelator alters cell cycle regulatory protein binding in breast cancer cells compared to normal breast cells.
    Pahl PM, Reese SM, Horwitz LD.
    J Exp Ther Oncol; 2007 Sep 12; 6(3):193-200. PubMed ID: 17552359
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB, Lovejoy DB, Watts RN, Richardson DR.
    Clin Cancer Res; 2003 Jan 12; 9(1):402-14. PubMed ID: 12538494
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase.
    Green DA, Antholine WE, Wong SJ, Richardson DR, Chitambar CR.
    Clin Cancer Res; 2001 Nov 12; 7(11):3574-9. PubMed ID: 11705879
    [Abstract] [Full Text] [Related]

  • 9. An exochelin of Mycobacterium tuberculosis reversibly arrests growth of human vascular smooth muscle cells in vitro.
    Pahl PM, Yan XD, Hodges YK, Rosenthal EA, Horwitz MA, Horwitz LD.
    J Biol Chem; 2000 Jun 09; 275(23):17821-6. PubMed ID: 10748174
    [Abstract] [Full Text] [Related]

  • 10. Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors.
    Yu Y, Kalinowski DS, Kovacevic Z, Siafakas AR, Jansson PJ, Stefani C, Lovejoy DB, Sharpe PC, Bernhardt PV, Richardson DR.
    J Med Chem; 2009 Sep 10; 52(17):5271-94. PubMed ID: 19601577
    [No Abstract] [Full Text] [Related]

  • 11. Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall.
    Gobin J, Horwitz MA.
    J Exp Med; 1996 Apr 01; 183(4):1527-32. PubMed ID: 8666910
    [Abstract] [Full Text] [Related]

  • 12. The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase.
    Cooper CE, Lynagh GR, Hoyes KP, Hider RC, Cammack R, Porter JB.
    J Biol Chem; 1996 Aug 23; 271(34):20291-9. PubMed ID: 8702762
    [Abstract] [Full Text] [Related]

  • 13. Desferri-Exochelin, a lipid-soluble, hexadentate iron chelator, effectively removes tissue iron.
    Hodges YK, Weinberger HD, Stephens J, Horwitz MA, Horwitz LD.
    Transl Res; 2006 Aug 23; 148(2):63-71. PubMed ID: 16890146
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sensitization of P388 murine leukemia cells to hydroxyurea cytotoxicity by hydrophobic iron-chelating agents.
    Satyamoorthy K, Chitnis M, Basrur V.
    Anticancer Res; 1986 Aug 23; 6(2):329-33. PubMed ID: 3518597
    [Abstract] [Full Text] [Related]

  • 18. Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators.
    Nyholm S, Mann GJ, Johansson AG, Bergeron RJ, Gräslund A, Thelander L.
    J Biol Chem; 1993 Dec 15; 268(35):26200-5. PubMed ID: 8253740
    [Abstract] [Full Text] [Related]

  • 19. Plasma membrane ferric reductase activity of iron-limited algal cells is inhibited by ferric chelators.
    Sonier MB, Weger HG.
    Biometals; 2010 Dec 15; 23(6):1029-42. PubMed ID: 20508972
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory mechanisms of heterocyclic carboxaldehyde thiosemicabazones for two forms of human ribonucleotide reductase.
    Zhu L, Zhou B, Chen X, Jiang H, Shao J, Yen Y.
    Biochem Pharmacol; 2009 Nov 01; 78(9):1178-85. PubMed ID: 19576866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.